MUC1 and lung cancer: In the present study, the median serum KL-6 levels were significantly higher in the DILD or AE-ILD subgroups than in the RP or non-ILD subgroups, whereas the patients with RP were not significantly different from those with non-ILD lung cancer in this regard.